Skip to content
akaturk Academic measurement
Sign in Sign up
2025 SJR Q3 JCR Q3 · 2 212 matched articles SCIE

Journal detail

Endocrine, Metabolic and Immune Disorders - Drug Targets

Publisher
Bentham Science Publishers
Country
United Arab Emirates · Middle East
Type
journal
ISSN
  • 18715303
  • 22123873
Scopus 0,552 SJR
Scopus Q3 SJR Q
WoS Q3 JCR Q
WoS 2 JIF
Scopus 69 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,552
  • Quartile Q3
  • H-Index 69
  • Cites/doc 2,28
  • Docs (3y) 483
  • Cites (3y) 1.112

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 2
  • 5Y JIF 2,1
  • JCI 0,4

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

Areas

WoS categories

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 Q3 0,552 2 2,1 0,4 Q3 69
2024 Q3 Q3 0,535 2 2 0,45 Q3 66
2023 Q3 Q3 0,495 2 2,2 0,42 Q3 66
2022 Q3 Q4 0,427 1,9 2 0,41 Q3 66
2021 Q3 Q4 0,49 2,4 2,5 0,47 Q3 66
2020 Q3 Q3 0,518 2,9 3 0,55 Q3 66
2019 Q3 Q3 0,465 2 2,2 0,43 Q3 66
2018 — Q4 — 1,1 1,8 0,46 Q3 —
2017 Q2 Q3 0,742 2 — 0,55 Q3 66
2016 Q3 Q3 0,648 1,9 — — — 66
2015 Q2 Q3 0,757 2 — — — 66
2014 Q2 — 0,679 — — — — 66
2013 Q2 — 0,836 — — — — 66
2012 Q2 — 0,819 — — — — 66
2011 Q2 — 0,753 — — — — 66
2010 Q2 — 0,979 — — — — 66

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q4 152/198
2025 IMMUNOLOGY SCIE Q4 Q4 149/183
2025 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 249/356
2024 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 141/193
2024 IMMUNOLOGY SCIE Q4 Q4 143/183
2024 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 232/352
2023 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q4 134/186
2023 IMMUNOLOGY SCIE Q4 Q4 144/181
2023 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 222/354
2022 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q4 128/145
2022 IMMUNOLOGY SCIE Q4 Q4 144/161
2022 PHARMACOLOGY & PHARMACY SCIE Q4 Q3 224/278
2021 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q3 124/146
2021 IMMUNOLOGY SCIE Q4 Q3 138/162
2021 PHARMACOLOGY & PHARMACY SCIE Q4 Q3 212/279
2020 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 105/146
2020 IMMUNOLOGY SCIE Q3 Q3 118/162
2020 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 170/276
2019 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q3 116/143
2019 IMMUNOLOGY SCIE Q4 Q4 129/159
2019 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 197/271
2018 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q3 134/145
2018 IMMUNOLOGY SCIE Q4 Q4 148/158
2018 PHARMACOLOGY & PHARMACY SCIE Q4 Q3 237/267
2017 ENDOCRINOLOGY & METABOLISM SCIE Q4 Q3 111/142
2017 IMMUNOLOGY SCIE Q4 Q3 126/155
2017 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 172/261
2016 ENDOCRINOLOGY & METABOLISM SCIE Q4 — 105/138
2016 IMMUNOLOGY SCIE Q4 — 119/151
2016 PHARMACOLOGY & PHARMACY SCIE Q3 — 174/257
2015 ENDOCRINOLOGY & METABOLISM SCIE Q4 — 100/133
2015 IMMUNOLOGY SCIE Q4 — 116/151
2015 PHARMACOLOGY & PHARMACY SCIE Q3 — 157/255